Kelly Chin, MD

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Actelion(MODEST), Bayer Healthcare Pharmaceuticals(MODEST), United therapeutics(MODEST), Merck & Co., Inc.(MODEST), Gossamer Bio(MODEST) RESEARCH/RESEARCH GRANTS: Actelion(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Arena(MODEST)

View Full Disclosure